BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 29151329)

  • 1. INVASIVE FUNGAL INFECTIONS IN CHILDREN TREATED FOR HEMATOLOGIC MALIGNANCIES - A FIVE-YEAR SINGLE CENTER EXPERIENCE.
    Buljan D; Kranjčec I; Pavić I; Krnjaić P; Šalig S; Jakovljević G; Stepan Giljević J
    Acta Clin Croat; 2022 Dec; 61(4):647-654. PubMed ID: 37868174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate, Risk Factors, and Outcomes of Invasive Fungal Infections in Patients with Hematologic Malignancies.
    Afhami S; Adibimehr A; Mousavi SA; Vaezi M; Montazeri M; Salehi M; Meidani M; Saleh M; Ahmadikia K; Roilides E; Maertens J; Alijani N
    Int J Hematol Oncol Stem Cell Res; 2024 Jan; 18(1):75-82. PubMed ID: 38680718
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology and Risk Factors for Invasive Fungal Infections in Pancreas Transplant in the Absence of Postoperative Antifungal Prophylaxis.
    Zachary J; Chen JM; Sharfuddin A; Yaqub M; Lutz A; Powelson J; Fridell JA; Barros N
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad478. PubMed ID: 37942464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Prospective Study to Evaluate the Effect of Therapeutic Drug Monitoring-Based Posaconazole Prophylaxis on Invasive Fungal Infection Rate During Acute Myeloid Leukemia Induction Therapy.
    Boppana M; Sengar M; Jain H; Gurjar M; Ambotkar M; Gota V; Bonda A; Bagal B; Thorat J; Gokarn A; Nayak L; Shetty N; Baheti A; Mokal S; Kannan S; Shetty A; Eipe T
    Indian J Hematol Blood Transfus; 2024 Apr; 40(2):204-212. PubMed ID: 38708158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive Fungal Infections in Children with Acute Leukemia: Epidemiology, Risk Factors, and Outcome.
    Gal Etzioni TR; Fainshtain N; Nitzan-Luques A; Goldstein G; Weinreb S; Temper V; Korem M; Averbuch D
    Microorganisms; 2024 Jan; 12(1):. PubMed ID: 38257971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical vs pre-emptive broad-spectrum antifungal therapy for acute myelogenous leukaemia in the era of antimould prophylaxis.
    Oh SM; Byun JM; Lee CM; Kang CK; Shin DY; Koh Y; Hong J; Choe PG; Park WB; Kim NJ; Yoon SS; Kim I; Oh MD
    Int J Antimicrob Agents; 2023 Oct; 62(4):106954. PubMed ID: 37595849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain.
    Moya-Alarcón C; Azanza JR; Barberán J; Ferrer R; Kwon M; Moreno A; Rubio-Terrés C; Gálvez-Santisteban M
    Expert Rev Anti Infect Ther; 2024 Mar; ():1-8. PubMed ID: 38494912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review on the epidemiology of invasive fungal infections in Asian patients with haematological malignancies (2011-2021).
    Iyadorai T; Tee TS; Chiat LC; Chandramathi S; Chee CL; Sum CC; Velayuthan R; Tan SM; Gin GG
    Epidemiol Rev; 2024 May; ():. PubMed ID: 38778757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Mold-Active Antifungal Prophylaxis Decreases the Need for Chest Computed Tomography Scans in Patients with Acute Lymphoblastic Leukemia.
    Karadaş N; Özdemir HH; Yilmaz Y; Göktepe ŞÖ; Ece D; Karapinar DY
    Indian J Hematol Blood Transfus; 2024 Apr; 40(2):196-203. PubMed ID: 38708155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into invasive fungal infection diagnostic and treatment capacities in tertiary care centres of Germany.
    Salmanton-García J; Simon M; Groll AH; Kurzai O; Lahmer T; Lehrnbecher T; Schroeder M; Cornely OA; Stemler J
    JAC Antimicrob Resist; 2024 Jun; 6(3):dlae083. PubMed ID: 38812581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).
    Mellinghoff SC; Panse J; Alakel N; Behre G; Buchheidt D; Christopeit M; Hasenkamp J; Kiehl M; Koldehoff M; Krause SW; Lehners N; von Lilienfeld-Toal M; Löhnert AY; Maschmeyer G; Teschner D; Ullmann AJ; Penack O; Ruhnke M; Mayer K; Ostermann H; Wolf HH; Cornely OA
    Ann Hematol; 2018 Feb; 97(2):197-207. PubMed ID: 29218389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Management of Chronic Pulmonary Aspergillosis: The UK National Aspergillosis Centre Approach.
    Maghrabi F; Denning DW
    Curr Fungal Infect Rep; 2017; 11(4):242-251. PubMed ID: 29213345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isavuconazole shortens the QTc interval.
    Mellinghoff SC; Bassetti M; Dörfel D; Hagel S; Lehners N; Plis A; Schalk E; Vena A; Cornely OA
    Mycoses; 2018 Apr; 61(4):256-260. PubMed ID: 29178247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection.
    Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A
    Biomedicines; 2017 Nov; 5(4):. PubMed ID: 29156624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea.
    Guery R; Henry B; Martin-Blondel G; Rouzaud C; Cordoliani F; Harms G; Gangneux JP; Foulet F; Bourrat E; Baccard M; Morizot G; Consigny PH; Berry A; Blum J; Lortholary O; Buffet P;
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006094. PubMed ID: 29155816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective Observational Multi-institutional Study on Invasive Fungal Infections Following Chemotherapy for Acute Myeloid Leukemia (MISFIC Study): A Real World Scenario from India.
    George B; Menon H; Bhurani D; Damodar S; Apte S; Seth T; Sharma A; Shyam R; Malhotra P; Easow J; Lakshmi KM; Agrawal N; Sengar M; Nataraj KS; Ahmed R; Sharma S; Khadwal A; Prakash G; Abraham A; Devasia A; Korula A; Mathews V
    Indian J Hematol Blood Transfus; 2020 Jan; 36(1):97-103. PubMed ID: 32158091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.
    Fracchiolla NS; Sciumè M; Orofino N; Guidotti F; Grancini A; Cavalca F; Freyrie A; Goldaniga MC; Consonni D; Mattiello V; Pettine L; Cortelezzi A
    PLoS One; 2019; 14(5):e0216715. PubMed ID: 31071175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and analysis of invasive fungal infections in patients withhematological malignancies: a single-center real-life experience.
    Soyer N; Kiper Ünal HD; Vural F; Şahin F; Töbü M; Dönmez A; Tombuloğlu M; Arda B; Saydam G
    Turk J Med Sci; 2017 Nov; 47(5):1535-1542. PubMed ID: 29151329
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.